These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3581647)
1. Sustained reductions in oxipurinol renal clearance during a restricted diet. Park GD; Berlinger WG; Spector R; Kitt TM; Tsalikian E Clin Pharmacol Ther; 1987 Jun; 41(6):616-21. PubMed ID: 3581647 [TBL] [Abstract][Full Text] [Related]
2. The effect of dietary protein on the clearance of allopurinol and oxypurinol. Berlinger WG; Park GD; Spector R N Engl J Med; 1985 Sep; 313(13):771-6. PubMed ID: 4033706 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone. Colin JN; Farinotti R; Fredj G; Tod M; Clavel JP; Vignon E; Dietlin F Eur J Clin Pharmacol; 1986; 31(1):53-8. PubMed ID: 3780828 [TBL] [Abstract][Full Text] [Related]
4. Reduced renal clearance of oxypurinol during a 400 calorie protein-free diet. Kitt TM; Park GD; Spector R; Tsalikian E J Clin Pharmacol; 1989 Jan; 29(1):65-71. PubMed ID: 2708550 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects. Turnheim K; Krivanek P; Oberbauer R Br J Clin Pharmacol; 1999 Oct; 48(4):501-9. PubMed ID: 10583019 [TBL] [Abstract][Full Text] [Related]
6. Renal clearances of oxypurinol and inulin on an isocaloric, low-protein diet. Kitt TM; Park GD; Spector R; Lawton W; Tsalikian E Clin Pharmacol Ther; 1988 Jun; 43(6):681-7. PubMed ID: 3378389 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a thiazide-allopurinol drug interaction. Hande KR Am J Med Sci; 1986 Oct; 292(4):213-6. PubMed ID: 3752167 [TBL] [Abstract][Full Text] [Related]
9. Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. II. Kinetics of allopurinol, oxipurinol, and hydrochlorothiazide. de Vries JX; Voss A; Ittensohn A; Walter-Sack I; Löffler W; Landthaler R; Zöllner N Clin Investig; 1994 Dec; 72(12):1076-81. PubMed ID: 7711419 [TBL] [Abstract][Full Text] [Related]
10. Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics. Löffler W; Landthaler R; de Vries JX; Walter-Sack I; Ittensohn A; Voss A; Zöllner N Clin Investig; 1994 Dec; 72(12):1071-5. PubMed ID: 7711418 [TBL] [Abstract][Full Text] [Related]
11. Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion. Day RO; Miners JO; Birkett DJ; Whitehead A; Naidoo D; Hayes J; Savdie E Br J Clin Pharmacol; 1988 Oct; 26(4):423-8. PubMed ID: 3190992 [TBL] [Abstract][Full Text] [Related]
12. [A study of serum oxipurinol concentration and renal function in patients administered allopurinol]. Saji M Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):640-50. PubMed ID: 9014485 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide. Breithaupt B; Tittel M Eur J Clin Pharmacol; 1982; 22(1):77-84. PubMed ID: 7094977 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of allopurinol, oxipurinol and uric acid in human plasma by high-performance liquid chromatography. Nissen P J Chromatogr; 1982 Mar; 228():382-6. PubMed ID: 7076766 [No Abstract] [Full Text] [Related]
15. Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol? Mertz DP; Eichhorn R Klin Wochenschr; 1984 Dec; 62(24):1170-2. PubMed ID: 6530890 [TBL] [Abstract][Full Text] [Related]
16. [Influence of benzbromarone on the pharmacokinetics and pharmacodynamics of oxipurinol]. Rüffer C; Zorn G; Henkel E; Mitzkat HJ Arzneimittelforschung; 1982; 32(9):1149-52. PubMed ID: 6890841 [TBL] [Abstract][Full Text] [Related]
17. [Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)]. Walter-Sack I; Gröbner W; Zöllner N Arzneimittelforschung; 1979; 29(5):839-42. PubMed ID: 582985 [TBL] [Abstract][Full Text] [Related]
18. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Hande KR; Noone RM; Stone WJ Am J Med; 1984 Jan; 76(1):47-56. PubMed ID: 6691361 [TBL] [Abstract][Full Text] [Related]
19. Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol. Walter-Sack I; de Vries JX; Ernst B; Frei M; Kolb S; Kosmowski J; Priebe U; Schroder HE; Slotty C; Voss A; Weber A; Wegscheider K J Rheumatol; 1996 Mar; 23(3):498-501. PubMed ID: 8832991 [TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatography with polarographic and voltammetric anodic detection: simultaneous determination of allopurinol, oxipurinol and uric acid in body fluids. Palmisano F; Desimoni E; Zambonin PG J Chromatogr; 1984 Mar; 306():205-14. PubMed ID: 6715459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]